The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Mechanism of Action of the Nongenotoxic Peroxisome Proliferators: Role of the Peroxisome Proliferator-Activated Receptor
Abstract
Peroxisome proliferators are a diverse group of chemicals that include several therapeutically used drugs (e.g., hypolipidemic agents), plasticizers and organic solvents used in the chemical industry, herbicides, and naturally occurring hormones. As the name implies, peroxisome proliferators cause an increase in the number and size of peroxisomes in the liver, kidney, and heart tissue of susceptible species, such as rats and mice. Long-term administration of peroxisome proliferators can cause liver cancer in these animals, a response that has been the central issue of research on peroxisome proliferators for many years. Peroxisome proliferators are representative of the class of nongenotoxic carcinogens that cause cancer through mechanisms that do not involve direct DNA damage. The fact that humans are frequently exposed to these agents makes them of particular concern to government regulatory agencies responsible for assuring human safety. Whether frequent exposure to peroxisome proliferators represents a hazard to humans is unknown; however, increased cancer risk has not been shown to be associated with long-term therapeutic administration of the hypolipidemic drugs gemfibrozil, fenofibrate, and clofibrate. To make sound judgments regarding the safety of peroxisome proliferators, the validity of extrapolating results from rodent bioassays to humans must be based on the agents' mechanism of action and species differences in biologic activity and carcinogenicity. The peroxisome proliferator-activated receptor alpha (PPARalpha), a member of the nuclear receptor superfamily, has been found to mediate the activity of peroxisome proliferators in mice. Gene-knockout mice lacking PPARalpha are refractory to peroxisome proliferation and peroxisome proliferator-induced changes in gene expression. Furthermore, PPARalpha-null mice are resistant to hepatocarcinogenesis when fed a diet containing a potent nongenotoxic carcinogen WY-14,643. Recent studies have revealed that humans have considerably lower levels of PPARalpha in liver than rodents, and this difference may, in part, explain the species differences in the carcinogenic response to peroxisome proliferators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,908
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Environmental Health Perspectives
Goehl, T. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.110-1240809 · Cited by 1,924
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Self-citationThe PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345
Self-citationShepard, T. H. (1981) · Teratology · doi:10.1002/tera.1420230118 · Cited by 1,296
Adipogenesis and Obesity: Rounding Out the Big Picture
Spiegelman, B. M., & Flier, J. S. (1996) · Cell · doi:10.1016/s0092-8674(00)81359-8 · Cited by 1,269
Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., & Gonzalez, F. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5678 · Cited by 863
Self-citationHypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
Reddy, J. K., Azarnoff, D. L., & Hignite, C. E. (1980) · Nature · doi:10.1038/283397a0 · Cited by 837
Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids
Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C. P., McMahon, G., Brown, M., & Lazar, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23975 · Cited by 711
Martin, G., Schoonjans, K., Lefebvre, A.-M., Staels, B., & Auwerx, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28210 · Cited by 551
Motojima, K., Passilly, P., Peters, J. M., Gonzalez, F. J., & Latruffe, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16710 · Cited by 524
Self-citationSher, T., Yi, H. F., McBride, O. W., & Gonzalez, F. J. (1993) · Biochemistry · doi:10.1021/bi00072a015 · Cited by 519
Self-citationPeroxisome proliterator-activated receptors, orphans with ligands and functions
Schoonjans, K., Martin, G., Staels, B., & Auwerx, J. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00006 · Cited by 489
Peters, J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.11.2029 · Cited by 479
Self-citationPeroxisome proliferator activated receptor-alpha expression in human liver.
Palmer, C. N., Hsu, M. H., Griffin, K. J., Raucy, J. L., & Johnson, E. F. (1998) · PubMed · Cited by 448
Alterations in Lipoprotein Metabolism in Peroxisome Proliferator-activated Receptor α-deficient Mice
Peters, J. M., Hennuyer, N., Staels, B., Fruchart, J.-C., Fievet, C., Gonzalez, F. J., & Auwerx, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27307 · Cited by 429
Self-citationPeroxisome Proliferator Activated Receptor-α Expression in Human Liver
Palmer, C. N. A., Hsu, M.-H., Griffin, K. J., Raucy, J. L., & Johnson, E. F. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.1.14 · Cited by 416
Marsman, D. S., Cattley, R. C., Conway, J. G., & Popp, J. A. (1988) · PubMed · Cited by 353
Self-citationFan, C.-Y., Pan, J., Usuda, N., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15639 · Cited by 343
Ashby, J., Brady, A., Elcombe, C. R., Elliott, B. M., Ishmael, J., Odum, J., Tugwood, J. D., Kettle, S., & Purchase, I. F. H. (1994) · Human & Experimental Toxicology · doi:10.1177/096032719401300201 · Cited by 313
Mukherjee, R., Jow, L., Noonan, D., & McDonnell, D. P. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90089-2 · Cited by 270
Ren, B., Thelen, A. P., Peters, J. M., Gonzalez, F. J., & Jump, D. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26827 · Cited by 264
Self-citationDo Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
Cattley, R. C., DeLuca, J., Elcombe, C., Fenner-Crisp, P., Lake, B. G., Marsman, D. S., Pastoor, T. A., Popp, J. A., Robinson, D. E., Schwetz, B., et al. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1997.1163 · Cited by 244
Self-citationKasai, H., Okada, Y., Nishimura, S., Rao, M. S. R., & Reddy, J. K. (1989) · PubMed · Cited by 230
Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis
Reddy, J. K., & Rao, M. S. (1989) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(89)90198-x · Cited by 193
Varanasi, U., Chu, R., Huang, Q., Castellon, R., Yeldandi, A. V., & Reddy, J. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2147 · Cited by 169
Peters, J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.11.1989 · Cited by 161
Self-citationPeroxisome proliferator-activated receptors: finding the orphan a home
Green, S., & Wahli, W. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90294-1 · Cited by 158
Human Carcinogens So Far Identified
Tomatis, L., Aitio, A., Wilbourn, J. D., & Shuker, L. K. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb01717.x · Cited by 158
PPAR Tissue Distribution and Interactions with Other Hormone‐Signaling Pathwaysa
Lemberger, T., Braissant, O., Juge-Aubry, C. E., KELLER, H., Saladin, R., Staels, B., Auwerx, J. H., Burger, A., Meier, C. A., & Wahli, W. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18619.x · Cited by 156
Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regression
Grasl‐Kraupp, B., Ruttkay-Nedecký, B., Müllauer, L., Taper, H., Huber, W. W., Bursch, W., & Schulte‐Hermann, R. (1997) · Hepatology · doi:10.1002/hep.510250420 · Cited by 146
Peroxisome Proliferator‐activated Receptors: Stuctures and Function
Tugwood, J. D., Aldridge, T. C., Lambe, K. G., MACDONALD, N., & Woodyatt, N. J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18620.x · Cited by 145
Roberts, R. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.43 · Cited by 140
Induction of hepatic peroxisome proliferation in nonrodent species, including primates.
Reddy, J. K., Lalwani, N. D., Qureshi, S. A., Reddy, M. K., & Moehle, C. M. (1984) · PubMed · Cited by 134
Butterworth, B. E., Conolly, R. B., & Morgan, K. T. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03794-w · Cited by 130
Auwerx, J. H., Schoonjans, K., Fruchart, J., & Staels, B. (1996) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.3.81 · Cited by 120
Conway, J. G., Tomaszewski, K. E., Olson, M. J., Cattley, R. C., Marsman, D. S., & Popp, J. A. (1989) · Carcinogenesis · doi:10.1093/carcin/10.3.513 · Cited by 118
Self-citationLake, B. G., Evans, J. G., Gray, T. J. B., Körösi, S. A., & North, C. J. (1989) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(89)90120-8 · Cited by 116
Metabolic pathways in mammalian peroxisomes
Mannaerts, G. P., & Veldhoven, P. P. V. (1993) · Biochimie · doi:10.1016/0300-9084(93)90072-z · Cited by 112
Peroxisome Proliferator–induced Pleiotropic Responses: Pursuit of a Phenomenona
Reddy, J. K., & Chu, R. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18616.x · Cited by 110
Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators
Rose, M. (1997) · Carcinogenesis · doi:10.1093/carcin/18.8.1453 · Cited by 87
A Nordic data base on somatic chromosome damage in humans
Brögger, A., Hagmar, L., Hansteen, I., Heim, S., Högstedt, B., Knudsen, L. E., Lambert, B., Linnainmaa, K., Mitelman, F., Nordenson, I., et al. (1990) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(90)90031-v · Cited by 87
Perturbation of the Mitosis/Apoptosis Balance: A Fundamental Mechanism in Toxicology,
Roberts, R. A. (1997) · Fundamental and Applied Toxicology · doi:10.1006/faat.1997.2331 · Cited by 87
Marsman, D. S., & Popp, J. A. (1994) · Carcinogenesis · doi:10.1093/carcin/15.1.111 · Cited by 78
Marsman, D. S., Goldsworthy, T. L., & Popp, J. A. (1992) · Carcinogenesis · doi:10.1093/carcin/13.6.1011 · Cited by 76
Krishna, G., Kropko, M. L., & Theiss, J. C. (1989) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(89)90036-0 · Cited by 72
Takagi, A., Sai, K., Umemura, T., Hasegawa, R., & Kurokawa, Y. (1990) · Cancer Letters · doi:10.1016/0304-3835(90)90007-k · Cited by 71
Chu, S., Huang, Q. M., Alvares, K., Yeldandi, A. V., Rao, M. S. R., & Reddy, J. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7080 · Cited by 66
Possible Mechanisms in Hepatocarcinogensis by the Peroxisome Proliferator Di(2-Ethylhexyl)Phthalate
Conway, J. G., Cattley, R. C., Popp, J. A., & Butterworth, B. E. (1989) · Drug Metabolism Reviews · doi:10.3109/03602538909029956 · Cited by 66
Self-citationPeroxisome proliferators activate Kupffer cells in vivo.
Bojes, H. K., & Thurman, R. G. (1996) · PubMed · Cited by 56
Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis
Lake, B. G. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03513-3 · Cited by 52
Cunningham, M. L., Soliman, M. S., Badr, M. Z., & Matthews, H. B. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03869-x · Cited by 48
Miller, R. T., Glover, S. E., Stewart, W. S., Corton, J. C., Popp, J. A., & Cattley, R. C. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1337 · Cited by 47
Self-citationNon‐genotoxic Hepatocarcinogenesis: Suppression of Apoptosis by Peroxisome Proliferators
Roberts, R. A. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18647.x · Cited by 44
Tsutsui, T., Watanabe, E., & Barrett, J. C. (1993) · Carcinogenesis · doi:10.1093/carcin/14.4.611 · Cited by 40
Peroxisome Proliferators: Species Differences in Response of Primary Hepatocyte Cultures
Elcombe, C. R., Bell, D., Elias, E., Hasmall, S. C., & Plant, N. J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18649.x · Cited by 40
Rininger, J. A. (1997) · Carcinogenesis · doi:10.1093/carcin/18.5.935 · Cited by 37
Peroxisome proliferation and hepatocarcinogenesis.
Jk, R., & Rao, M. S. R. (1992) · PubMed · Cited by 36
Evidence against peroxisome proliferation-induced hepatic oxidative damage
Soliman, M. S., Cunningham, M. L., Morrow, J. D., et al. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)87956-7 · Cited by 28
Grasl‐Kraupp, B., Huber, W., Timmermann-Trosiener, I., et al. (1993) · Carcinogenesis · doi:10.1093/carcin/14.11.2435 · Cited by 27
Ma, X., Stoffregen, D. A., Wheelock, G. D., Rininger, J. A., & Babish, J. G. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.1.69 · Cited by 20
Rininger, J. A., Wheelock, G. D., Ma, X., & Babish, J. G. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00596-5 · Cited by 17
Jones, H. B., Eldridge, S. R., Butterworth, B. E., & Foster, J. (1996) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1996.0033 · Cited by 17
Mikalsen, S., Kaalhus, O., Reith, A., & Sanner, T. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460533 · Cited by 12
Cited by
Role of ROS and RNS Sources in Physiological and Pathological Conditions
Di Meo, S., Reed, T. T., Venditti, P., & Victor, V. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1245049 · Cited by 1,614
Reddy, J. K., & Hashimoto, T. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.193 · Cited by 959
Peroxisomes and oxidative stress
Schrader, M., & Fahimi, H. D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.09.006 · Cited by 838
Waxman, D. J. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1351 · Cited by 753
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
Horie, Y., Suzuki, A., Kataoka, E., Sasaki, T., Hamada, K., Sasaki, J., Mizuno, K., Hasegawa, G., Kishimoto, H., Iizuka, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420513 · Cited by 698
Metadata
- Authors
- Gonzalez, F. J., Peters, J. M., & Cattley, R. C.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-11-18
- Volume
- 90
- Issue
- 22
- Pages
- 1702-1709
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2123998830
- Cited by
- 290
- References
- 67
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.